Harmony Biosciences Holdings (HRMY) Income towards Parent Company (2019 - 2025)
Historic Income towards Parent Company for Harmony Biosciences Holdings (HRMY) over the last 7 years, with Q3 2025 value amounting to $50.9 million.
- Harmony Biosciences Holdings' Income towards Parent Company rose 1035.3% to $50.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $157.7 million, marking a year-over-year increase of 4438.4%. This contributed to the annual value of $117.5 million for FY2024, which is 178.37% up from last year.
- According to the latest figures from Q3 2025, Harmony Biosciences Holdings' Income towards Parent Company is $50.9 million, which was up 1035.3% from $39.8 million recorded in Q2 2025.
- In the past 5 years, Harmony Biosciences Holdings' Income towards Parent Company ranged from a high of $87.9 million in Q3 2022 and a low of -$9.6 million during Q3 2021
- For the 5-year period, Harmony Biosciences Holdings' Income towards Parent Company averaged around $30.6 million, with its median value being $29.5 million (2023).
- Data for Harmony Biosciences Holdings' Income towards Parent Company shows a peak YoY increase of 5238518.52% (in 2021) and a maximum YoY decrease of 60392.88% (in 2021) over the last 5 years.
- Over the past 5 years, Harmony Biosciences Holdings' Income towards Parent Company (Quarter) stood at $19.1 million in 2021, then skyrocketed by 154.53% to $48.5 million in 2022, then crashed by 72.81% to $13.2 million in 2023, then surged by 62.84% to $21.5 million in 2024, then skyrocketed by 136.86% to $50.9 million in 2025.
- Its Income towards Parent Company stands at $50.9 million for Q3 2025, versus $39.8 million for Q2 2025 and $45.6 million for Q1 2025.